83 results on '"Weber, Sharon M."'
Search Results
2. Association of Neighborhood Disadvantage with Short- and Long-Term Outcomes After Pancreatectomy for Pancreatic Ductal Adenocarcinoma
3. ASO Visual Abstract: Very Early Recurrence After Curative-Intent Surgery for Gastric Adenocarcinoma
4. Very Early Recurrence After Curative-Intent Surgery for Gastric Adenocarcinoma
5. ASO Visual Abstract: Rethinking Routine Intensive Care After Cytoreductive Surgery with Heated Intraperitoneal Chemotherapy: The Fiscal Argument
6. Rethinking Routine Intensive Care After Cytoreductive Surgery With Heated Intraperitoneal Chemotherapy: The Fiscal Argument
7. ASO Visual Abstract: Incidence of Second Primary Melanoma in Survivors of Cutaneous Melanoma
8. Incidence of Second Primary Melanoma in Cutaneous Melanoma Survivors
9. ASO Visual Abstract: Does the Volume-Outcome Association in Pancreas Cancer Justify Regionalization of Care? A Review of Current Controversies
10. ASO Visual Abstract: Development of a Prognostic Nomogram and Nomogram Software Application Tool to Predict Overall Survival and Disease-Free Survival After Curative-Intent Gastrectomy for Gastric Cancer
11. ASO Author Reflections: Understanding the Broader Implications of the Volume–Outcome Impact on Pancreas Cancer Surgery
12. Does the Volume-Outcome Association in Pancreas Cancer Surgery Justify Regionalization of Care? A Review of Current Controversies
13. Development of a Prognostic Nomogram and Nomogram Software Application Tool to Predict Overall Survival and Disease-Free Survival After Curative-Intent Gastrectomy for Gastric Cancer
14. Surgical Strategies for Bismuth Type I and II Hilar Cholangiocarcinoma: Impact on Long-Term Outcomes
15. What Drives High Costs of Cytoreductive Surgery and HIPEC: Patient, Provider or Tumor?
16. Current Advances in Minimally Invasive Surgical Management of Perihilar Cholangiocarcinoma
17. National Underutilization of Neoadjuvant Chemotherapy for Gastric Cancer
18. Correction to: Current Approaches in the Management of Hepatic Adenomas
19. Editorial About: “A Prospective, Open-Label, Multicenter Phase II Trial of Neoadjuvant Therapy Using Full-Dose Gemcitabine and S-1 Concurrent with Radiation for Resectable Pancreatic Ductal Adenocarcinoma”
20. National Trends in Centralization of Surgical Care and Multimodality Therapy for Pancreatic Adenocarcinoma
21. Defining the Role of Lymphadenectomy for Pancreatic Neuroendocrine Tumors: An Eight-Institution Study of 695 Patients from the US Neuroendocrine Tumor Study Group
22. Association of Perioperative Transfusion with Recurrence and Survival After Resection of Distal Cholangiocarcinoma: A 10-Institution Study from the US Extrahepatic Biliary Malignancy Consortium
23. Natural History and Treatment Trends in Pancreatic Cancer Subtypes
24. Predictive Value of Chromogranin A and a Pre-Operative Risk Score to Predict Recurrence After Resection of Pancreatic Neuroendocrine Tumors
25. Actual 5-Year Survivors After Surgical Resection of Hilar Cholangiocarcinoma
26. Current Approaches in the Management of Hepatic Adenomas
27. The Impact of Hospital Neoadjuvant Therapy Utilization on Survival Outcomes for Pancreatic Cancer
28. The Impact of Intraoperative Re-Resection of a Positive Bile Duct Margin on Clinical Outcomes for Hilar Cholangiocarcinoma
29. A Novel T-Stage Classification System for Adrenocortical Carcinoma: Proposal from the US Adrenocortical Carcinoma Study Group
30. Surgical Site Infection Is Associated with Tumor Recurrence in Patients with Extrahepatic Biliary Malignancies
31. Time to Initiation of Adjuvant Chemotherapy in Pancreas Cancer: A Multi-Institutional Experience
32. Gallbladder Cancer Presenting with Jaundice: Uniformly Fatal or Still Potentially Curable?
33. Human pancreatic stellate cells modulate 3D collagen alignment to promote the migration of pancreatic ductal adenocarcinoma cells
34. A Novel Pathology-Based Preoperative Risk Score to Predict Locoregional Residual and Distant Disease and Survival for Incidental Gallbladder Cancer: A 10-Institution Study from the U.S. Extrahepatic Biliary Malignancy Consortium
35. Minimally Invasive Resection of Adrenocortical Carcinoma: a Multi-Institutional Study of 201 Patients
36. Lymphadenectomy for Adrenocortical Carcinoma: Is There a Therapeutic Benefit?
37. Changing Odds of Survival Over Time among Patients Undergoing Surgical Resection of Gallbladder Carcinoma
38. A Comparison of Prognostic Schemes for Perihilar Cholangiocarcinoma
39. Impact of Chemotherapy and External-Beam Radiation Therapy on Outcomes among Patients with Resected Gallbladder Cancer: A Multi-institutional Analysis
40. Prognostic Implications of Lymph Node Status for Patients With Gallbladder Cancer: A Multi-Institutional Study
41. Assessing Trends in Palliative Surgery for Extrahepatic Biliary Malignancies: A 15-Year Multicenter Study
42. Readmission Following Gastric Cancer Resection: Risk Factors and Survival
43. Interaction of Postoperative Morbidity and Receipt of Adjuvant Therapy on Long-Term Survival After Resection for Gastric Adenocarcinoma: Results From the U.S. Gastric Cancer Collaborative
44. Preoperative Helicobacter pylori Infection is Associated with Increased Survival After Resection of Gastric Adenocarcinoma
45. Incidence of Perioperative Complications Following Resection of Adrenocortical Carcinoma and Its Association with Long-Term Survival
46. Is Linitis Plastica a Contraindication for Surgical Resection: A Multi-Institution Study of the U.S. Gastric Cancer Collaborative
47. To Roux or not to Roux: a comparison between Roux-en-Y and Billroth II reconstruction following partial gastrectomy for gastric cancer
48. Incidence and Risk Factors Associated with Readmission After Surgical Treatment for Adrenocortical Carcinoma
49. Adrenocortical Carcinoma: Impact of Surgical Margin Status on Long-Term Outcomes
50. Curative Resection of Adrenocortical Carcinoma: Rates and Patterns of Postoperative Recurrence
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.